» Articles » PMID: 37108204

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 28
PMID 37108204
Authors
Affiliations
Soon will be listed here.
Abstract

The United States is experiencing the most profound and devastating opioid crisis in history, with the number of deaths involving opioids, including prescription and illegal opioids, continuing to climb over the past two decades. This severe public health issue is difficult to combat as opioids remain a crucial treatment for pain, and at the same time, they are also highly addictive. Opioids act on the opioid receptor, which in turn activates its downstream signaling pathway that eventually leads to an analgesic effect. Among the four types of opioid receptors, the µ subtype is primarily responsible for the analgesic cascade. This review describes available 3D structures of the µ opioid receptor in the protein data bank and provides structural insights for the binding of agonists and antagonists to the receptor. Comparative analysis on the atomic details of the binding site in these structures was conducted and distinct binding interactions for agonists, partial agonists, and antagonists were observed. The findings in this article deepen our understanding of the ligand binding activity and shed some light on the development of novel opioid analgesics which may improve the risk benefit balance of existing opioids.

Citing Articles

Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor.

Cooper D, DePaolo-Boisvert J, Nicholson S, Gad B, Minh D J Chem Inf Model. 2025; 65(3):1465-1475.

PMID: 39824514 PMC: 11817682. DOI: 10.1021/acs.jcim.4c01437.


Intracellular pocket conformations determine signaling efficacy through the opioid receptor.

Cooper D, DePaolo-Boisvert J, Nicholson S, Gad B, Minh D bioRxiv. 2024; .

PMID: 39677660 PMC: 11642773. DOI: 10.1101/2024.04.03.588021.


Structural basis of μ-opioid receptor targeting by a nanobody antagonist.

Yu J, Kumar A, Zhang X, Martin C, Van Holsbeeck K, Raia P Nat Commun. 2024; 15(1):8687.

PMID: 39384768 PMC: 11464722. DOI: 10.1038/s41467-024-52947-6.


Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development.

Li Z, Huang R, Xia M, Chang N, Guo W, Liu J Molecules. 2024; 29(11).

PMID: 38893511 PMC: 11173883. DOI: 10.3390/molecules29112635.


The Role of Pro-Opiomelanocortin Derivatives in the Development of Type 2 Diabetes-Associated Myocardial Infarction: Possible Links with Prediabetes.

Gumede N, Khathi A Biomedicines. 2024; 12(2).

PMID: 38397916 PMC: 10887103. DOI: 10.3390/biomedicines12020314.


References
1.
Faouzi A, Wang H, Zaidi S, DiBerto J, Che T, Qu Q . Structure-based design of bitopic ligands for the µ-opioid receptor. Nature. 2022; 613(7945):767-774. PMC: 10328120. DOI: 10.1038/s41586-022-05588-y. View

2.
Sakkiah S, Kusko R, Pan B, Guo W, Ge W, Tong W . Structural Changes Due to Antagonist Binding in Ligand Binding Pocket of Androgen Receptor Elucidated Through Molecular Dynamics Simulations. Front Pharmacol. 2018; 9:492. PMC: 5962723. DOI: 10.3389/fphar.2018.00492. View

3.
Sassone-Corsi P . The cyclic AMP pathway. Cold Spring Harb Perspect Biol. 2012; 4(12). PMC: 3504441. DOI: 10.1101/cshperspect.a011148. View

4.
Bartuzi D, Kaczor A, Matosiuk D . Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics. J Chem Inf Model. 2015; 55(11):2421-34. DOI: 10.1021/acs.jcim.5b00280. View

5.
Pettersen E, Goddard T, Huang C, Meng E, Couch G, Croll T . UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2020; 30(1):70-82. PMC: 7737788. DOI: 10.1002/pro.3943. View